← All trials
NCT03836833
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 4, 2019
- Primary completion
- Nov 30, 2019
- Completion date
- Dec 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Drugs for Neglected Diseases InitiativeLead sponsor
- Institute of Tropical Medicine, BelgiumCollaborator
- UNITAIDCollaborator
- Joint Clinical Research Centre, Kampala, UgandaCollaborator
- Epcentre Centre Mbarara Research CentreCollaborator
- Drugs for Neglected Diseases InitiativeStudy director
- Baylor UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.